Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
pregabalin, Quantity: 225 mg
Lupin Australia Pty Limited
Pregabalin
Capsule, hard
Excipient Ingredients: pregelatinised maize starch; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; iron oxide red; Gelatin; sodium lauryl sulfate; ethanol absolute
Oral
60, 20, 14, 56
(S4) Prescription Only Medicine
Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Visual Identification: Size '1' capsules with light brown cap and white body, imprinted with "PG" on cap and "225" on body in black ink, containing white to off white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-12-05